Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2012
06/06/2012EP2460520A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459564A2 Cyclopropyl modulators of p2y12 receptor
06/06/2012EP2459557A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
06/06/2012EP2459543A1 Benzo [e][1, 3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
06/06/2012EP2459507A1 Use of erythritol for the prevention or treatment of hypertension
06/06/2012EP2459222A1 Sticky soft gel for treating poultry
06/06/2012EP2459200A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders
06/06/2012EP2459193A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients
06/06/2012EP2459182A1 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
06/06/2012EP1909912B1 Use of collismycin A as oxidative stress inhibitor
06/06/2012EP1661579B1 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna
06/06/2012EP1633718B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
06/06/2012EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/06/2012CN1997651B Oxidative degradation products of atorvastatin calcium
06/06/2012CN1935839B Analogues of GLP-1
06/06/2012CN1582282B Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
06/06/2012CN1342158B 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
06/06/2012CN102485724A Substituted thiazolyl pyrazolo pyridine compound and medical purpose thereof
06/06/2012CN102485717A Thiazolamine derivative and application thereof as sRNA virus infection resisting medicine
06/06/2012CN102485228A Pharmaceutical composition and purpose thereof
06/06/2012CN102485227A Medicine composition and applications thereof
06/06/2012CN102485223A Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease
06/06/2012CN102485221A Sublingual pharmaceutical composition containing ibutilide and preparation method thereof
06/06/2012CN102485219A Diltiazem hydrochloride delayed release bilayer osmotic pump controlled released tablet and its preparation method
06/06/2012CN102485218A Clopidogrel hydrogen sulfate tablet and preparation method thereof
06/06/2012CN102205014B Method for processing rhizoma arisaematis
06/06/2012CN102008684B Traditional Chinese medicine composition for curing level-IV chemotherapeutic phlebitis
06/06/2012CN101947287B Oral traditional Chinese medicine for treating haemorrhoids
06/06/2012CN101940785B Hydrogen sulfide-producing enzyme preparation and use thereof
06/06/2012CN101920019B Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate
06/06/2012CN101863951B Method for preparing eplerenone
06/06/2012CN101766683B Salvia dispersible tablet and application thereof
06/06/2012CN101732402B Medicament for preventing and treating ischemic brain injury, and preparation method thereof
06/06/2012CN101712704B Method for preparing flavonoid compounds, used intermediate and preparation method thereof
06/06/2012CN101638404B High-purity salvianolic acid B and preparation method and application thereof
06/06/2012CN101564496B Plaster for mainly curing periarthritis of shoulder
06/06/2012CN101549109B Medicament for treating cerebral atherosclerosis
06/06/2012CN101530482B Application of ranunculin in preparing medicines for curing cardiovascular diseases
06/06/2012CN101511369B Methods and compositions for inhibiting angiogenesis.
06/06/2012CN101439099B Chinese medicine granule containing red paeonia extract and preparation method thereof
06/06/2012CN101416964B Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus
06/06/2012CN101084997B Traditional Chinese medicine freezing-dried powder injection for treating cardiovascular and cerebrovascular diseases and its preparing method
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
06/05/2012US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
06/05/2012US8193151 Methods for treating atrial or ventricular arrhythmias
06/05/2012US8192987 Human dental follicle stem cells and methods for obtaining
06/05/2012US8192753 pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same
06/05/2012US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
06/05/2012CA2671816C Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2520740C Process for the preparation of amorphous calcium salt of atorvastatin
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
06/05/2012CA2418238C Method for treating unstable angina pectoris
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012071186A1 Modulators of s1p receptors
05/31/2012WO2012071184A1 Indole derivatives as modulators of s1p receptors
05/31/2012WO2012071152A2 Method of treating neurological conditions with extract of nerium species or thevetia species
05/31/2012WO2012070972A1 Method for treating cardiovascular disease patients
05/31/2012WO2012070969A1 Diagnostic method for predicting the development of cardiovascular diseases and monitoring treatment efficacy
05/31/2012WO2012070621A1 Use of age-specific aptamer for treating renal disease
05/31/2012WO2012070554A1 Peptide
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069620A1 Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
05/31/2012WO2012068962A1 Use of compound salvia miltiorrhiza preparation in preparing medicament for resisting pulmonary hypertension
05/31/2012WO2012068870A1 Ternary complex, liquid containing ternary complex, preparing method and use thereof
05/31/2012WO2012048059A3 Bepotastine compositions
05/31/2012WO2012040595A9 Administration of serine protease inhibitors to the stomach
05/31/2012WO2012033789A3 Treatment of diseases
05/31/2012WO2012008764A3 Composition for inducing multiple nuclear division of cells
05/31/2012WO2011162562A3 [6+5] fused bicycles as a thrombin antagonist, process for preparation thereof and pharmaceutical compositions containing the bicycles
05/31/2012US20120137379 Novel aav's and uses thereof
05/31/2012US20120136157 Aryl ureas as kinase inhibitors
05/31/2012US20120136141 Integrin Heterodimer And A Subunit Thereof
05/31/2012US20120136052 Substituted acylanilides and methods of use thereof
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136041 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136025 Quinolone derivative or pharmaceutically acceptable salt thereof
05/31/2012US20120136015 Process for preparation of endothelial receptor antagonist (bosentan)
05/31/2012US20120136013 Organic compounds
05/31/2012US20120136007 Methods and compositions for treating degenerative and ischemic disorders
05/31/2012US20120136006 Cold menthol receptor antagonists
05/31/2012US20120136003 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
05/31/2012US20120136001 Substituted oxindole derivatives, medicaments containing the latter and use thereof
05/31/2012US20120135996 Cytoprotective agent
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135992 Cyclic triazo sodium channel blockers
05/31/2012US20120135985 Substituted piperidines
05/31/2012US20120135984 Dual-action inhbitors and methods of using same
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135964 Certain chemical entities, compositions, and methods
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 1595